Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesHow should a nonfunctioning pituitary macroadenoma be monitored after debulking surgery
Clinical Endocrinology, 05/28/09
Greenman Y et al. - Transsphenoidal surgery is the treatment of choice for nonfunctioning pituitary macroadenomas but is seldom curative. Tumour progression rates are high in patients with postoperative remnants. Therefore, long-term monitoring is necessary to detect tumour growth, which may be asymptomatic or manifest with visual field defects and/or pituitary dysfunction. In view of the generally slow-growing nature of these tumours, yearly magnetic resonance imaging, neuro-ophalmologic and pituitary function evaluation are appropriate during the first 3-5 years after surgery. If there is no evidence for tumour progression during this period, testing intervals may be extended thereafter.
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
CAGS and ACS Evidence-Based Reviews in Surgery. 31 The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis
Canadian Journal of Surgery, 12/18/09
Ultrasound-assisted Microsurgery for Cushing's Disease
Experimental and Clinical Endocrinology & Diabetes, 12/17/09
Neonatal small left colon syndrome in the offspring of diabetic mothers—an analysis of 105 children
Journal of Pediatric Surgery, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor